Alto Neuroscience (ANRO) has had the highest return between September 18, 2025 and December 18, 2025 by a small-cap US stock, returning 393.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Alto Neuroscience (ANRO) | 9/18/2025 - 12/18/2025 | 393.65% |
Capricor Therapeutics (CAPR) | 9/18/2025 - 12/18/2025 | 320.39% |
AXT (AXTI) | 9/18/2025 - 12/18/2025 | 245.93% |
Ventyx Biosciences (VTYX) | 9/18/2025 - 12/18/2025 | 229.36% |
Inhibrx Biosciences (INBX) | 9/18/2025 - 12/18/2025 | 218.36% |
Resolute Holdings Management (RHLD) | 9/18/2025 - 12/18/2025 | 208.25% |
MBX Biosciences, Inc Common Stock (MBX) | 9/18/2025 - 12/18/2025 | 186.7% |
Kodiak Sciences (KOD) | 9/18/2025 - 12/18/2025 | 186.12% |
PepGen (PEPG) | 9/18/2025 - 12/18/2025 | 173.68% |
Immix Biopharma (IMMX) | 9/18/2025 - 12/18/2025 | 173.21% |
Forge Global (FRGE) | 9/18/2025 - 12/18/2025 | 172.96% |
Relmada Therapeutics (RLMD) | 9/18/2025 - 12/18/2025 | 171.24% |
Alumis (ALMS) | 9/18/2025 - 12/18/2025 | 167.15% |
Northern Dynasty Minerals (NAK) | 9/18/2025 - 12/18/2025 | 163.41% |
Lyell Immunopharma (LYEL) | 9/18/2025 - 12/18/2025 | 160.71% |
NovaBay Pharmaceuticals (NBY) | 9/18/2025 - 12/18/2025 | 156.48% |
Ironwood Pharmaceuticals (IRWD) | 9/18/2025 - 12/18/2025 | 154.69% |
Hycroft Mining (HYMC) | 9/18/2025 - 12/18/2025 | 152.63% |
Monte Rosa Therapeutics (GLUE) | 9/18/2025 - 12/18/2025 | 146.96% |
BioAge Labs (BIOA) | 9/18/2025 - 12/18/2025 | 143.7% |
AnaptysBio (ANAB) | 9/18/2025 - 12/18/2025 | 139.81% |
Sight Sciences (SGHT) | 9/18/2025 - 12/18/2025 | 138.73% |
Replimune (REPL) | 9/18/2025 - 12/18/2025 | 135.19% |
Hotel101 Global Holdings Corp Class A Ordinary Shares (HBNB) | 9/18/2025 - 12/18/2025 | 130.23% |
DBV Technologies (DBVT) | 9/18/2025 - 12/18/2025 | 123.47% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
